EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Efficacy and Safety of Anthracyclines Combined with Temozolomide Regimens for the Treatment of Advanced Leiomyosarcoma: A Retrospective Study

Huijing Tan, Jianguo Zhou, Susheng Shi iD, Liming Jiang, Lijie Zuo, Aijiang Su, Huike Wang iD, Yuting Sun, Wenjuan Xuan, Yihebali Chi

Therapeutics and Clinical Risk Management · 2026-04 · Volume 22 · 1-16

DOI: 10.2147/tcrm.s564176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutics and Clinical Risk Management, 2026-04. Verfasst von Huijing Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

advanced leiomyosarcomaanthracyclineschemotherapyctDNAtemozolomide

Autor:innen und Institutionen

  • Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republ…
  • Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's R…
  • Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of C…
  • Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Repu…
  • Department of Medical Oncology, Beijing Chaoyang Sanhuan Cancer Hospital, Beijing, 100021, People's Republic of China.

ORCID-Profile: Susheng Shi, Huike Wang

Zitieren

APA

Tan, H., Zhou, J., Shi, S., Jiang, L., Zuo, L., Su, A., Wang, H., Sun, Y., Xuan, W., & Chi, Y. (2026). Efficacy and Safety of Anthracyclines Combined with Temozolomide Regimens for the Treatment of Advanced Leiomyosarcoma: A Retrospective Study. Therapeutics and Clinical Risk Management, Volume 22, 1-16. https://doi.org/10.2147/tcrm.s564176

Vancouver

Tan H, Zhou J, Shi S, Jiang L, Zuo L, Su A, et al. Efficacy and Safety of Anthracyclines Combined with Temozolomide Regimens for the Treatment of Advanced Leiomyosarcoma: A Retrospective Study. Therapeutics and Clinical Risk Management. 2026;Volume 22:1-16. doi:10.2147/tcrm.s564176

BibTeX
@article{Tan2026,
  author = {Tan, Huijing and Zhou, Jianguo and Shi, Susheng and Jiang, Liming and Zuo, Lijie and Su, Aijiang and Wang, Huike and Sun, Yuting and Xuan, Wenjuan and Chi, Yihebali},
  title = {Efficacy and Safety of Anthracyclines Combined with Temozolomide Regimens for the Treatment of Advanced Leiomyosarcoma: A Retrospective Study},
  journal = {Therapeutics and Clinical Risk Management},
  year = {2026},
  volume = {Volume 22},
  pages = {1--16},
  doi = {10.2147/tcrm.s564176}
}
Kostenlos starten →